2. Academic Validation
  3. Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma. A Canadian National Cancer Institute Clinical Trial Group study

Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma. A Canadian National Cancer Institute Clinical Trial Group study

  • Invest New Drugs. 1993 May-Aug;11(2-3):235-7. doi: 10.1007/BF00874163.
J A Maroun 1,  J Skillings,  R MacCormick,  M Potvin,  G Wielgosz,  J R Davidson,  E Eisenhauer
Affiliations

Affiliation

  • 1 Ottawa Regional Cancer Centre, Canada.
PMID: 8262739 DOI: 10.1007/BF00874163
Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z